Counting alleles to predict recurrence of early-stage colorectal cancers.
about
Epigenetic inactivation of the canonical Wnt antagonist SRY-box containing gene 17 in colorectal cancerSensitive and efficient detection of RB1 gene mutations enhances care for families with retinoblastomaAllelic imbalances of chromosomes 8p and 18q and their roles in distant relapse of early stage, node-negative breast cancer.The emerging role of GATA transcription factors in development and diseasePrinciple and applications of digital PCRMyotubularin-related protein 7 inhibits insulin signaling in colorectal cancerGlobal gene expression profiling: a complement to conventional histopathologic analysis of neoplasia.18q loss of heterozygosity in microsatellite stable colorectal cancer is correlated with CpG island methylator phenotype-negative (CIMP-0) and inversely with CIMP-low and CIMP-high.Microfluidic digital PCR enables rapid prenatal diagnosis of fetal aneuploidyGene dysregulations driven by somatic copy number aberrations-biological and clinical implications in colon tumors: a paper from the 2009 William Beaumont Hospital Symposium on Molecular Pathology.Relationship between metabolic enzyme polymorphism and colorectal cancer.Hypermethylation of the GATA gene family in esophageal cancer.The chromosomal instability pathway in colon cancerSomatic mutations, allele loss, and DNA methylation of the Cub and Sushi Multiple Domains 1 (CSMD1) gene reveals association with early age of diagnosis in colorectal cancer patientsModern management of colorectal cancer--a pathologist's view.Tumour matrilysin expression predicts metastatic potential of stage I (pT1) colon and rectal cancers.Digital PCR for the molecular detection of fetal chromosomal aneuploidyDevelopment of a clinically feasible molecular assay to predict recurrence of stage II colon cancer.Noninvasive prenatal diagnosis of monogenic diseases by digital size selection and relative mutation dosage on DNA in maternal plasma.Tumour-infiltrating CD68+ and CD57+ cells predict patient outcome in stage II-III colorectal cancerEvaluation of 13q14 status in patients with chronic lymphocytic leukemia using single nucleotide polymorphism-based techniques.Evaluation of 13q14 status in multiple myeloma by digital single nucleotide polymorphism technology.Prognostic significance and molecular associations of 18q loss of heterozygosity: a cohort study of microsatellite stable colorectal cancers.CSMD1 exhibits antitumor activity in A375 melanoma cells through activation of the Smad pathway.A validated metabolomic signature for colorectal cancer: exploration of the clinical value of metabolomics.Frequent genomic loss at chr16p13.2 is associated with poor prognosis in colorectal cancer.Prognostic factors in 165 elderly colorectal cancer patients.Predictive value of vascular endothelial growth factor overexpression in early relapse of colorectal cancer patients after curative resection.Maternal Plasma DNA Sequencing Reveals the Genome-Wide Genetic and Mutational Profile of the FetusGenetic profiling of stage I and II colorectal cancer may predict metastatic relapse
P2860
Q24321845-966FC861-2C64-49DC-AD41-AD88B1AB86BFQ24611398-D7E266CE-A616-4292-9B42-705AFBBF11DBQ25257829-8B0E46B9-2C41-4F67-AEC1-212E7EB7C699Q28071681-CAA118F2-31B7-40DD-B32A-A4E19F2D5C4DQ28237698-4C6A2B52-ED84-4DB4-B03E-B14B5FDA4760Q28468649-AAA36817-1F1E-4F17-AE56-CBCDDA3BB61FQ33227605-E56B48B5-3D28-4D34-8703-0D2DF30B813DQ33283458-42B31565-752E-4484-B0A3-3B501717026BQ33980278-FD2C0D2E-6557-4E73-914F-0138E114F17CQ34084819-A69AC1CB-BEFB-4CB0-9432-BBB9F678196AQ34382213-BC8975DC-3A22-47FF-AD1E-BFCF9293C600Q34545175-02327755-8D5B-4238-9917-190110E437B3Q34570062-0A663C67-48AA-4733-A085-2BEB75382AE5Q34626018-12507C29-B8DA-4029-9896-E61A6C8F9E77Q35111158-04F18E53-E971-4162-9420-191188FC2B82Q35597953-4FB2CB54-BD59-4449-B8F5-8AD28DB1527EQ35916813-5AC3B682-2275-413B-AFBF-FB031BF54470Q36734636-FDFB39EC-9472-44E2-8E84-97FADC15AA16Q37000915-6D7CB75F-43EB-413F-820A-B7D464B322C7Q37111136-4F868853-2C3B-468C-AB66-DFA2F7FADD47Q37261857-5F55B25B-6029-4457-9096-8D8BDB49A896Q37312999-35666983-ADD0-4874-883A-1B91FD4F7390Q37369820-EE9CFA76-281F-4D08-A38A-953711CFE91EQ39357838-B487B93B-83FD-49B4-8898-4E31E0018819Q39454414-30A0A854-32D4-4620-BD33-F309792DAEA5Q39620506-7652F364-3379-46B7-8A73-233CFFDA7C27Q42154020-6B160D53-DC93-4B3C-AA92-2D8E1912C2F4Q44344925-1B449AB8-2659-4F74-9011-C34477711085Q56937251-9996BCEB-D966-496E-A232-CCA72A63715FQ57729114-262CF772-0695-4126-9364-33FE4E41E047
P2860
Counting alleles to predict recurrence of early-stage colorectal cancers.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Counting alleles to predict recurrence of early-stage colorectal cancers.
@en
Counting alleles to predict recurrence of early-stage colorectal cancers.
@nl
type
label
Counting alleles to predict recurrence of early-stage colorectal cancers.
@en
Counting alleles to predict recurrence of early-stage colorectal cancers.
@nl
prefLabel
Counting alleles to predict recurrence of early-stage colorectal cancers.
@en
Counting alleles to predict recurrence of early-stage colorectal cancers.
@nl
P2093
P50
P1433
P1476
Counting alleles to predict recurrence of early-stage colorectal cancers.
@en
P2093
Al Culliford
Carlo Pignatelli
David J Harrison
Elizabeth A Montgomery
Francesca Ferraraccio
Juan Piris
Katharine E Romans
Michael A Choti
Philip B Paty
P304
P356
10.1016/S0140-6736(02)07448-2
P407
P577
2002-01-01T00:00:00Z